Source: Annual Congress 2011 - Pulmonary infections and sepsis
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Khoury, H. Al-Nasser, F. Al-Hamad, H. Hannan (Aleppo, Syrian Arab Republic). De-escalation therapy in ventilator acquired pneumonia (VAP). Eur Respir J 2011; 38: Suppl. 55, 3208

Member's Comments

No comment yet.

Related content which might interest you: Ventilator – associated pneumonia (VAP) Source: Eur Respir J 2004; 24: Suppl. 48, 547s Year: 2004 Aerosolised treatment for VAP Source: Eur Respir Mon 2011; 53: 54-65 Year: 2011 NIV in community-acquired pneumonia Source: Annual Congress 2005 - Noninvasive ventilation (NIV) in hypoxaemic acute respiratory failure (ARF) Year: 2005 Diagnosis and treatment of nosocomial pneumonia in ALI/ARDS patients Source: Eur Respir J 2003; 22: 77S-83S Year: 2003 Non-invasive ventilation (NIV) in hospital-acquired pneumonia (HAP) of non-ICU COPD patients Source: Annual Congress 2008 - Noninvasive mechanical ventilation in the acute setting Year: 2008 Pulmonary apoptosis and related markers in ventilator acquired pneumonia (VAP) Source: Eur Respir J 2003; 22: Suppl. 45, 13s Year: 2003 VAP: approach to therapy Source: Eur Respir Mon 2011; 53: 36-47 Year: 2011 Optimising the duration of antibiotic therapy for ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 40-44 Year: 2007 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Pharmacokinetic optimisation of β-lactams for the treatment of ventilator-associated pneumonia Source: Eur Respir Rev 2007; 16: 45-49 Year: 2007 Switch from intravenous to oral antibiotic therapy in hospitalized patients with non-severe community acquired pneumonia Source: Annual Congress 2010 - New aspects of treatment of lower respiratory tract infections Year: 2010 Antibiotic treatment for nosocomial pneumonia Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211 Year: 2004 Implications of identifying the pathogen in ventilator-associated pneumonia (VAP) Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia Source: Eur Respir J 2011; 37: 1332-1339 Year: 2011 Predictors of clinical failure in community-acquired pneumonia Source: Annual Congress 2011 - PG9 Risk stratification and treatment of lower respiratory tract infections Year: 2011 Ventilator-associated pneumonia (VAP) – Early and late-onset differences Source: Annual Congress 2013 –Infection, sepsis and outcomes in ICU Year: 2013 Combination versus monotherapy for nosocomial pneumonia Source: Eur Respir Rev 2007; 16: 50-55 Year: 2007 Relationship between tracheotomy and ventilator-associated pneumonia: a case control study Source: Eur Respir J 2007; 30: 314-320 Year: 2007 Dynamic of adherence to guidelines for antibiotic therapy of community-aquired pneumonia (CAP) Source: Annual Congress 2013 –Antibiotics, resistance and vaccines Year: 2013 Inflammatory biomarkers in predicting ICU admission of severe community-acquired pneumonia (CAP) Source: Annual Congress 2011 - Pulmonary infections and sepsis Year: 2011